Datatrak Intl Inc (DTRK) 6.7500 $DTRK DATATRAK to

New Post Public Reply Private Reply Replies (0) Message Board

Jul 26, 2016 at 11:10 AM

Datatrak Intl Inc (DTRK) 6.7500 $DTRK

DATATRAK to Feature CTMS and Full Platform at Upcoming DIA 2016
PR Newswire - Thu Jun 16, 12:45PM CDT
DATATRAK International, Inc. (OTC Markets: DTRK), a leader in cloud-based, unified digital clinical technologies and related services for the clinical trials industry, today announced the full DATATRAK platform with an emphasis on the new CTMS solution, UX CTMS 360(TM), will be featured at DIA 2016.

Reduce Queries up to 90% with Integrated Imaging and EDC Technology
PR Newswire - Mon Jun 06, 7:00AM CDT
DATATRAK International, Inc. (OTC Markets: DTRK), a leader in cloud-based, unified digital clinical technologies and related services for the clinical trials industry, today announced the completion of a case study analyzing the partnership between DATATRAK and AG Mednet to successfully reduce queries by 90% in a recent trial with integrated technology.

Jim Bob Ward Named CEO of DATATRAK
PR Newswire - Mon May 23, 8:00AM CDT
DATATRAK International, Inc. (OTC Markets: DTRK), a leader in cloud-based, unified digital clinical technologies and related services for the clinical trials industry, today announced that interim CEO and founder of the software platform, Jim Bob Ward, has been named CEO and President.

DATATRAK International, Inc. Reports First Quarter Results of 2016
PR Newswire - Tue May 10, 8:00AM CDT
DATATRAK International, Inc. (OTC Markets: DTRK), a leader in cloud-based, unified dClinical® technologies and related services for the clinical trials industry, today announced its operating results for the first quarter of 2016.

DATATRAK International, Inc. Reports Fourth Quarter and Full Year Results of 2015
PR Newswire - Fri Apr 08, 5:33PM CDT
DATATRAK International, Inc. (OTCQX: DTRK), a leader in cloud-based, unified dClinical® technologies and related services for the clinical trials industry, today announced its operating results for the fourth quarter and full year 2015.

DATATRAK International, Inc., Timothy G. Biro, James M. Karis, Jerome H. Kaiser, Nicholas A. Loiacono, Tabatabai Investment Management LLC (f/k/a Arosa Investment Management LLC) and Alex Tabatabai Seek Court Approval of Proposed Settlement
PR Newswire - Mon Mar 07, 4:03PM CST
Pursuant to Ohio Rule of Civil Procedure 23.1 DATATRAK International, Inc. (OTCQX: DTRK), Timothy G. Biro, James M. Karis, Jerome H. Kaiser, Nicholas A. Loiacono and Andrew T. Pitler (collectively the "Released DATATRAK Parties"

on the one hand, and Tabatabai Investment Management LLC (f/k/a Arosa Investment Management LLC and Alex Tabatabai (collectively "Arosa"

(collectively the "Settling Parties"

on the other, hereby provide notice to DATATRAK Shareholders of a proposed partial settlement of DATATRAK International, Inc. v. Arosa Investment Management, LLC, et al., Cuyahoga County Court of Common Pleas Case No. CV-15-854059, currently being considered for final approval by the Honorable Michael E. Jackson (the "Proposed Settlement"

. The Proposed Settlement does not include former DATATRAK Chairman Laurence P. Birch, and the claims asserted by Arosa against Mr. Birch survive the Proposed Settlement.

DATATRAK & NTT Data Host Tokyo User Group Meeting
Marketwired - Wed Feb 03, 4:10PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies, today announced its participation in the FIRST NTT Data User Group meeting held in Tokyo, Japan.

DATATRAK's Technology Driven Drug Development (TD3) Supports Clinical Trial Industry Transformation
Marketwired - Thu Jan 14, 11:06AM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced that more than 100 CROs, 10 of the top 15 pharmaceutical organizations, and 3 top 10 biotechs, are using the DATATRAK ONE UX(TM) platform in their efforts to harness technology to drive drug development.

Arosa Investment Management Thanks Datatrak Shareholders and Vows to Faithfully Represent Their Best Interests
BusinessWire - Wed Jan 13, 12:24PM CST
Arosa Investment Management LLC wishes to express its gratitude for the outpouring of support from a broad base of shareholders over the prolonged election process that spilled over into a new year, included three scheduled meeting dates and required shareholders to submit ballots at least twice. Here are the figures from IVS Associates' Final Report of the Inspector of Elections:

DATATRAK Welcomes New Directors
Marketwired - Tue Jan 12, 5:11PM CST
Three new directors have been elected to the board of DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry. Prior to the next meeting of the Board of Directors, the Company also reiterated its commitment to serving its customers and remains optimistic about the Company's long-term opportunity to grow and thrive in the future.

Statement From DATATRAK's Board Regarding Annual Meeting and the Call to Work Constructively Going Forward
Marketwired - Thu Jan 07, 1:09PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today released a statement from its three Class II Directors who will remain in office regardless of the results of tomorrow's Annual Meeting of Shareholders.

Arosa Investment Management Alerts Shareholders to the Datatrak Board's Secretive Adoption of Golden Parachutes and By-law Amendments
BusinessWire - Wed Jan 06, 7:16PM CST
Arosa Investment Management LLC, the beneficial owner of approximately 9.9% of the shares of Datatrak International, Inc. (OTC

TRK) that initiated a proxy contest and obtained the most votes at two scheduled annual meetings that Datatrak management abruptly postponed, is alerting shareholders to the Datatrak board's secretive and shameless last-minute adoption of golden parachutes and by-law amendments.

DATATRAK Announces Settlement of Patent Litigation
Marketwired - Wed Jan 06, 8:02AM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced that it has entered into a settlement agreement with Medidata Solutions, Inc. to resolve all existing patent litigation between the parties.

Survey Says - DATATRAK Customer-Centric Approach Works
PR Newswire - Mon Jan 04, 9:32PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced that results from an internal client survey confirm that DATATRAK's customer-centric approach to clinical trial solutions has had a positive impact.

Arosa Investment Management Again Refutes Datatrak's Shameless and Phony Campaign of Misinformation Targeted Against Arosa
BusinessWire - Mon Jan 04, 5:59PM CST
Arosa Investment Management LLC, the beneficial owner of approximately 9.9% of the shares of Datatrak International, Inc. (OTC

TRK) that initiated a proxy contest and obtained the most votes at two scheduled annual meetings that Datatrak management abruptly postponed, again refutes Datatrak's shameless and phony campaign of misinformation targeted against Arosa.

DATATRAK Urges Shareholders To Reject Arosa's Claims
PR Newswire - Thu Dec 31, 3:23PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today called upon the shareholders to review the following information and reject Arosa's claims.

DATATRAK Technology and Clinical Research Expertise Bests Competitors
PR Newswire - Wed Dec 30, 7:53PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced top ranking content in the Clinical Leader Top 10 of 2015. A total of 5 DATATRAK authored articles were highlighted in the annual recap, more than any other source, with top spots in the White Paper and Case Study categories.

Arosa Investment Management Calls on Datatrak to Comply with Law and Stop Endless Delay and Entrenchment Actions; Calls on Chairman/CEO Larry Birch to Immediately Resign
BusinessWire - Wed Dec 30, 3:06PM CST
Arosa Investment Management LLC, the beneficial owner of approximately 9.9% of the shares of Datatrak International, Inc. (OTC

TRK) that initiated a proxy contest and has now obtained the most votes at two scheduled Annual Meetings that Datatrak management has abruptly delayed, calls on Datatrak to immediately hold the 2015 Annual Meeting and calls on Chairman/CEO Larry Birch to immediately resign.

DATATRAK Uncovers Smoking Gun Evidence Tying Alex Tabatabai to Serious Misconduct
PR Newswire - Tue Dec 29, 8:45PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced that the 2015 Annual Meeting of Shareholders has been postponed and will now take place at 10:00 am CT on Friday, January 8, 2015 at the Prudential Plaza Building, 180 North Stetson, Suite 1630, Chicago, IL 60601.

DATATRAK Files Motion To Dismiss Arosa's Specious Claims Relating To The Postponed Annual Meeting
PR Newswire - Tue Dec 22, 7:00AM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced that the Company has filed a motion to have the dissident's claims dismissed regarding previous postponement of the annual meeting.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Papa John's Faces Class Action Over Misleading Info

Trouble Brewing for Papa John's Investors Rolling the dice in the stock market sometimes feels like playing the lottery, doesn't it? This time around, it's Papa John's (NASDAQ: PZZA) serving up a slice of turmoil for its investors. The pizza chain's got itself tangled in a class-action lawsuit, and it's the shareholders who're left with a bitter taste. Investors Cry Foul...

Fast Guard Elevates Nationwide Fire Watch Mission

Fast Guard: The Unseen Shield Behind Property Safety Hollywood, Florida might be best known for its sun-kissed beaches, but in the world of fire safety, it’s the nerve center for emergency fire watch response. Fast Guard Service isn’t just any run-of-the-mill security outfit; it’s rapidly becoming the unsung hero of property managers across the nation. When those...

2026 Lantern Festival Shines in Kunshan Amid Tensions

Lanterns Illuminate Cross-Strait Relations Under the shadow of geopolitical tensions, the 2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival kicked off with a splash on September 16. Held in Kunshan, Suzhou, this cultural festival offers a rare glimpse of cooperation and shared cultural celebration across the Taiwan Strait. Through lantern displays, art exhibitions,...

Tragedy Highlights Need for E-bike Safety Overhaul

A Dire Wake-Up Call in the East Village We're staring hard at a heartbreaking mess in the East Village. A 15-year-old girl lost her life while riding an electric Citi Bike, hit by an industrial truck. Let's not dance around it—this is a gut punch, the kind you never want to ever hear about, and one that comes with a bitter flavor of 'what if?' Age Verification: A...

Med Spa Visits: Key Insights from Lindsey Smith

Moving Beyond the Fear Factor Stepping into a med spa for the first time can be nerve-wracking, especially if you're unsure of what to expect. Lindsey Smith, an expert from Flawless Med Spa in Bryant, Arkansas, knows just how critical it is to navigate this terrain with clarity. Her approach emphasizes building a foundation of trust and understanding from the get-go. Fear...

Shanghai's Arts Carnival Fuses Tech and Culture

Shanghai Heralds New Era in Arts with Carnival Coming in hot, Shanghai's ready to shake up the city's cultural scene with the 2026 International Audio-Visual Arts Carnival. It's happening in Jing'an District from September 24 to October 18, promising an experience that fuses travel, technology, and art. Just about anyone can catch a break from their daily grind and dive...

Flying Car Regulatory Sandbox Begins in UAE

Pioneering Flying Cars in the Desert In a move that seems right out of a science fiction screenplay, ARIDGE—the bigwig of flying cars from Asia—has taken a giant leap. They’ve cozied up with the UAE, locking arms to cook up the world's first regulatory sandbox for personal flying cars. Now, don’t laugh—sandbox isn't just for toddlers. It’s the playground where...

Hainan Airlines' Dedication Keeps It atop Skytrax

Fifteen years of soaring high: now that's something worth taking to the bank—or the air. Hainan Airlines has just bagged the SKYTRAX Five-Star Airline rating once again, handed out at this year's World Airline Awards ceremony. When it comes to delivering quality, they're flying high on the charts, landing among the World's Best Airlines Top 10. And in the wild world of...

Insta360 Expands with Times Square Flagship Store

Insta360 Times Square Opening Marks Bold Expansion I dropped by Times Square today, and what do I see? Insta360 planting its flag right in the heart of New York City. Now, this isn't your run-of-the-mill grand opening—it’s the first flagship store outside of Asia, and it screams of big ambitions. Nestled at 1515 Broadway, the store is smack in the middle of one of the...

Quay Dominates 2026 Sunglasses Review for Variety

Sunglasses Designed for Every Face Type When it comes to picking the right pair of shades, face shape is only part of the equation. Expert Consumers just dropped their 2026 verdict, spotlighting Quay as the go-to brand for those wider faces, tricky nose bridges, and the noggins that run a tad larger than average. Forget what you heard about one-size-fits-all. This...